Sperduto, P. W., Shanley, R., Luo, X., Kased, N., Sneed, P. K., Roberge, D., … Mehta, M. P. (2012). EVIDENCE OF INTERACTION BETWEEN HER2 AND ESTROGEN/PROGESTERONE (ER/PR) RECEPTOR STATUS IN PATIENTS WITH BREAST CANCER AND BRAIN METASTASES. In NEURO-ONCOLOGY (Vol. 14, pp. 66–67). Washington, DC: OXFORD UNIV PRESS INC.

Sperduto, Paul W., Ryan Shanley, Xianghua Luo, Norbert Kased, Penny K. Sneed, David Roberge, Samuel Chao, et al. “EVIDENCE OF INTERACTION BETWEEN HER2 AND ESTROGEN/PROGESTERONE (ER/PR) RECEPTOR STATUS IN PATIENTS WITH BREAST CANCER AND BRAIN METASTASES.” In NEURO-ONCOLOGY, 14:66–67. OXFORD UNIV PRESS INC, 2012.

Sperduto PW, Shanley R, Luo X, Kased N, Sneed PK, Roberge D, et al. EVIDENCE OF INTERACTION BETWEEN HER2 AND ESTROGEN/PROGESTERONE (ER/PR) RECEPTOR STATUS IN PATIENTS WITH BREAST CANCER AND BRAIN METASTASES. In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2012. p. 66–7.

Sperduto, Paul W., et al. “EVIDENCE OF INTERACTION BETWEEN HER2 AND ESTROGEN/PROGESTERONE (ER/PR) RECEPTOR STATUS IN PATIENTS WITH BREAST CANCER AND BRAIN METASTASES.” NEURO-ONCOLOGY, vol. 14, OXFORD UNIV PRESS INC, 2012, pp. 66–67.

Sperduto PW, Shanley R, Luo X, Kased N, Sneed PK, Roberge D, Chao S, Weil R, Suh J, Bhatt A, Jensen A, Brown PD, Shih H, Kirkpatrick J, Gaspar LE, Fiveash J, Chiang V, Knisely J, Sperduto CM, Lin N, Mehta MP. EVIDENCE OF INTERACTION BETWEEN HER2 AND ESTROGEN/PROGESTERONE (ER/PR) RECEPTOR STATUS IN PATIENTS WITH BREAST CANCER AND BRAIN METASTASES. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2012. p. 66–67.